Cargando…
Pristimerin inhibits glioma progression by targeting AGO2 and PTPN1 expression via miR-542-5p
Glioblastoma multiform is the most common and malignant primary tumor of the central nervous system in adults, the high recurrence rate and poor prognosis are critical priorities. Pristimerin is a naturally occurring quinone methide triterpenoid isolated from the Celastraceae and Hippocrateaceae fam...
Autores principales: | Li, Zaiyu, Hu, Cong, Zhen, Yu, Pang, Bo, Yi, Huanfa, Chen, Xianglin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Portland Press Ltd.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6522714/ https://www.ncbi.nlm.nih.gov/pubmed/31015365 http://dx.doi.org/10.1042/BSR20182389 |
Ejemplares similares
-
Pristimerin Suppressed Breast Cancer Progression via miR-542-5p/DUB3 Axis
por: Cheng, Shihuan, et al.
Publicado: (2020) -
Pristimerin Suppresses Trophoblast Cell Epithelial–Mesenchymal Transition via miR-542-5p/EGFR Axis
por: Shu, Chang, et al.
Publicado: (2020) -
MicroRNAs miR-19, miR-340, miR-374 and miR-542 regulate MID1 protein expression
por: Unterbruner, Kristoffer, et al.
Publicado: (2018) -
miR-542-3p Contributes to the HK2-Mediated High Glycolytic Phenotype in Human Glioma Cells
por: Kim, Junhyung, et al.
Publicado: (2021) -
MiR-542-5p Inhibits Hyperglycemia and Hyperlipoidemia by Targeting FOXO1 in the Liver
por: Tian, Fang, et al.
Publicado: (2020)